Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis (Q39038603)

8 September 2017

Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis (English)

1 reference

non-alcoholic steatohepatitis

8 September 2017

0 references

0 references

1 reference

Mustafa Cengiz

1

1 reference

PubMed ID

25684563

8 September 2017

Seren Ozenirler

series ordinal

2

1 reference

PubMed ID

25684563

8 September 2017

Sehri Elbeg

series ordinal

3

1 reference

8 September 2017

1 July 2015

1 reference

Journal of Gastroenterology and Hepatology

8 September 2017

1 reference

8 September 2017

30

1 reference

8 September 2017

7

1 reference

8 September 2017

1190-1196

1 reference

Nonalcoholic steatohepatitis: pathologic features and differential diagnosis

8 September 2017

1 reference

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

21 January 2018

1 reference

Noninvasive methods to assess liver disease in patients with hepatitis B or C.

21 January 2018

1 reference

Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?

21 January 2018

1 reference

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver

21 January 2018

1 reference

Toll-like receptors as targets in chronic liver diseases

21 January 2018

1 reference

Role of gut microbiota in liver diseases

21 January 2018

1 reference

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

21 January 2018

1 reference

c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice

21 January 2018

1 reference

Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis.

21 January 2018

1 reference

Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity

21 January 2018

1 reference

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

TLR2-mediated production of IL-27 and chemokines by respiratory epithelial cells promotes bleomycin-induced pulmonary fibrosis in mice.

21 January 2018

1 reference

Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses.

21 January 2018

1 reference

Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Rodent models for metabolic syndrome research

21 January 2018

1 reference

Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

21 January 2018

1 reference

Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells

21 January 2018

1 reference

Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk

21 January 2018

1 reference

Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling

21 January 2018

1 reference

The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes

21 January 2018

1 reference

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

21 January 2018

1 reference

Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats

21 January 2018

1 reference

Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells

21 January 2018

1 reference

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats

21 January 2018

1 reference

Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis

21 January 2018

1 reference

Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD

21 January 2018

1 reference

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

21 January 2018

1 reference

Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12924

1 reference

8 September 2017

1 reference

PubMed ID

25684563